Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.52 |
| ▸ | TP53 | P04637 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27467352 | 0.76 | MEN1 (0.52) | MEN1KMT2A | |
| Hydrochloric Acid SCHEMBL27473778 | 0.74 | MEN1 (0.50) | MEN1KMT2A | |
| Hydrochloric Acid SCHEMBL27514980 | 0.70 | MEN1 (0.46) | MEN1KMT2A | |
| SCHEMBL226273 | 0.69 | MEN1 (1.00) | MEN1KMT2ATP53TSHR | |
| SCHEMBL2990827 | 0.69 | MEN1 (1.00) | MEN1KMT2ATP53TSHR | |
| SCHEMBL11299976 | 0.69 | MEN1 (0.50) | MEN1KMT2A | |
| SCHEMBL7516996 | 0.67 | TP53 (0.50) | TP53TSHRTDP1 | |
| SCHEMBL1133203 | 0.67 | MEN1 (0.62) | MEN1KMT2A | |
| Phosphine SCHEMBL27652671 | 0.67 | MEN1 (0.94) | MEN1KMT2ATP53TSHR | |
| SCHEMBL27834982 | 0.67 | MEN1 (0.94) | MEN1KMT2ATP53TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7049073-B2 | Double stranded nucleic acid biochips | THE UNIVERSITY OF CHICAGO (US) | 2006-05-23 | — | — | US | disclosed |
| US-20040086866-A1 | Using phosphoramidite compound; biosynthesis | U CHICAGO ARGONNE LLC | 2004-05-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040086866-A1 | Using phosphoramidite compound; biosynthesis | DNA2, COASY, DERA | MEN1 2708/4885KMT2A 1946/4885TP53 2940/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.